EA200000709A1 - Бета-липотропин и его применения - Google Patents
Бета-липотропин и его примененияInfo
- Publication number
- EA200000709A1 EA200000709A1 EA200000709A EA200000709A EA200000709A1 EA 200000709 A1 EA200000709 A1 EA 200000709A1 EA 200000709 A EA200000709 A EA 200000709A EA 200000709 A EA200000709 A EA 200000709A EA 200000709 A1 EA200000709 A1 EA 200000709A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lipotropin
- applications
- fragments
- analogues
- analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
(57) Настоящее изобретение представляет выделенные нуклеиновые кислоты, векторы, трансформированные клетки-хозяева, аналоги, функциональные фрагменты и гибридные белки, касающиеся β-липотропина. Также представляются фармацевтические композиции, содержащие β-липотропин или его фрагменты и (или) аналоги, а также способы лечения сахарного диабета и состояний, связанных с ним, путем введения эффективного количества β-липотропина.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6865997P | 1997-12-23 | 1997-12-23 | |
US7985798P | 1998-03-30 | 1998-03-30 | |
US8632198P | 1998-05-21 | 1998-05-21 | |
US9138598P | 1998-07-01 | 1998-07-01 | |
US9540598P | 1998-08-05 | 1998-08-05 | |
US10397698P | 1998-10-13 | 1998-10-13 | |
PCT/US1998/027238 WO1999032142A1 (en) | 1997-12-23 | 1998-12-21 | Beta-lipotropin and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200000709A1 true EA200000709A1 (ru) | 2000-12-25 |
Family
ID=27557000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000709A EA200000709A1 (ru) | 1997-12-23 | 1998-12-21 | Бета-липотропин и его применения |
Country Status (18)
Country | Link |
---|---|
US (2) | US6323178B1 (ru) |
EP (1) | EP0926239A3 (ru) |
JP (1) | JP2001526061A (ru) |
KR (1) | KR20010024805A (ru) |
CN (1) | CN1284882A (ru) |
AR (1) | AR018532A1 (ru) |
AU (1) | AU1938599A (ru) |
BR (1) | BR9814433A (ru) |
CA (1) | CA2315888A1 (ru) |
CO (1) | CO4930304A1 (ru) |
EA (1) | EA200000709A1 (ru) |
HR (1) | HRP20000426A2 (ru) |
HU (1) | HUP0100132A2 (ru) |
IL (1) | IL136514A0 (ru) |
PE (1) | PE20000062A1 (ru) |
PL (1) | PL341293A1 (ru) |
TR (1) | TR200002611T2 (ru) |
WO (1) | WO1999032142A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002048337A2 (en) * | 2000-12-13 | 2002-06-20 | Incyte Genomics, Inc. | Secreted human proteins |
US7910101B2 (en) | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
US8227194B2 (en) * | 2005-04-08 | 2012-07-24 | University Of Maryland, Baltimore | Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32) |
WO2009139846A1 (en) * | 2008-05-12 | 2009-11-19 | Department Of Veterans Affairs | Automated system and method for diabetes control |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769326A (en) | 1980-02-29 | 1988-09-06 | The Regents Of The University Of California | Expression linkers |
US5258496A (en) * | 1990-07-10 | 1993-11-02 | Scios Nova Inc. | Isolation and purification of lung surfactant protein |
JP3822232B2 (ja) * | 1993-08-30 | 2006-09-13 | ベイラー・カレッジ・オブ・メディシン | 老化細胞由来dna合成阻害因子 |
US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5691309A (en) * | 1995-01-31 | 1997-11-25 | Eli Lilly And Company | Anti-obesity proteins |
-
1998
- 1998-12-21 BR BR9814433-2A patent/BR9814433A/pt not_active IP Right Cessation
- 1998-12-21 AR ARP980106554A patent/AR018532A1/es not_active Application Discontinuation
- 1998-12-21 EA EA200000709A patent/EA200000709A1/ru unknown
- 1998-12-21 WO PCT/US1998/027238 patent/WO1999032142A1/en not_active Application Discontinuation
- 1998-12-21 EP EP98310498A patent/EP0926239A3/en not_active Withdrawn
- 1998-12-21 HU HU0100132A patent/HUP0100132A2/hu unknown
- 1998-12-21 TR TR2000/02611T patent/TR200002611T2/xx unknown
- 1998-12-21 AU AU19385/99A patent/AU1938599A/en not_active Abandoned
- 1998-12-21 KR KR1020007006954A patent/KR20010024805A/ko not_active Application Discontinuation
- 1998-12-21 US US09/217,228 patent/US6323178B1/en not_active Expired - Fee Related
- 1998-12-21 IL IL13651498A patent/IL136514A0/xx unknown
- 1998-12-21 CO CO98075718A patent/CO4930304A1/es unknown
- 1998-12-21 PE PE1998001260A patent/PE20000062A1/es not_active Application Discontinuation
- 1998-12-21 CN CN98813767A patent/CN1284882A/zh active Pending
- 1998-12-21 PL PL98341293A patent/PL341293A1/xx unknown
- 1998-12-21 JP JP2000525132A patent/JP2001526061A/ja not_active Withdrawn
- 1998-12-21 CA CA002315888A patent/CA2315888A1/en not_active Abandoned
-
2000
- 2000-06-23 HR HR20000426A patent/HRP20000426A2/hr not_active Application Discontinuation
-
2001
- 2001-04-02 US US09/824,438 patent/US20030073621A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR9814433A (pt) | 2000-10-10 |
HUP0100132A2 (hu) | 2001-05-28 |
CN1284882A (zh) | 2001-02-21 |
US20030073621A1 (en) | 2003-04-17 |
AU1938599A (en) | 1999-07-12 |
CA2315888A1 (en) | 1999-07-01 |
EP0926239A3 (en) | 2002-08-28 |
US6323178B1 (en) | 2001-11-27 |
AR018532A1 (es) | 2001-11-28 |
PL341293A1 (en) | 2001-04-09 |
EP0926239A2 (en) | 1999-06-30 |
KR20010024805A (ko) | 2001-03-26 |
PE20000062A1 (es) | 2000-02-08 |
HRP20000426A2 (en) | 2000-10-31 |
CO4930304A1 (es) | 2000-06-27 |
TR200002611T2 (tr) | 2000-12-21 |
JP2001526061A (ja) | 2001-12-18 |
IL136514A0 (en) | 2001-06-14 |
WO1999032142A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95115239A (ru) | Аналог эритропоэтина | |
PT96208A (pt) | Processo de obtencao de uma sequencia de adn codificando um derivado recombinante do factor viii humano, de um vector e de celula recombinante e de preparacao do referido derivado. | |
EA200000872A1 (ru) | Способы лечения диабета с помощью пептидных аналогов инсулина | |
DE69934967D1 (de) | Verfahren zur verminderung der immunogenität von proteinen | |
EP1798239A3 (en) | G-protein coupled receptors and uses therefor | |
PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
EA200901129A1 (ru) | Нуклеиновые кислоты и полипептиды нового рецептора | |
BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
EA199900939A1 (ru) | Остеопротегерин-связывающие белки и рецепторы | |
ATE114169T1 (de) | Morphogenetisches knochenprotein. | |
DE69027989D1 (de) | Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON | |
EA200000652A1 (ru) | Кристаллы глюкагоноподобного пептида 1 | |
CA2381219A1 (en) | Monomeric protein of the tgf-beta family | |
EA200000202A1 (ru) | Рекомбинантная экспрессия c-пептида инсулина | |
DE69504808D1 (de) | Corticotropin freisetzende rezeptoren des faktor 2 | |
ES2150495T3 (es) | Ligandos de flt3 purificados de mamifero y agonistas y antagonistas de los mismos. | |
Ouazana et al. | Biochemical characterization of the cuticle collagen of the nematode Caenorhabditis elegans | |
EA200000709A1 (ru) | Бета-липотропин и его применения | |
AMMER et al. | The major protamine from stallion sperm. Isolation and amino-acid sequence | |
ATE233321T1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
AR013801A1 (es) | Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la | |
ATE86260T1 (de) | Peptid-molekuele, wirksam gegen gram-positive keime. | |
NO874704L (no) | Minaktivin fremstilt ved rekombinant dna-teknikk. | |
ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
KR950003312A (ko) | 연골세포 단백질 |